OpenAI opens ChatGPT Health to all US users with records sync
OpenAI's health service exits its waitlist: US adults can link Apple Health and hospital records, while critics flag HIPAA gaps and a free-tier quality gap.
OpenAI has opened ChatGPT Health to every adult US user, converting January's waitlisted experiment into a nationwide product. The rollout, announced July 23, spans the Free, Go, Plus and Pro tiers on web and iOS, and lets users sync Apple Health data alongside medical records pulled from Epic and Oracle Health patient portals, plus services such as One Medical, Function and MyFitnessPal.
From a sandbox to everywhere
The original January release confined health conversations to a separate tab with its own memory. That wall is now gone: OpenAI says more than 70 percent of health conversations in early testing happened outside the dedicated space, so connected records can now inform any chat. The company also disclosed scale numbers — over 300 million people ask ChatGPT health questions weekly, up from 230 million in January. The feature was built with input from more than 260 licensed physicians, who wrote test scenarios and grading rubrics. On privacy, OpenAI promises connected health data is excluded from model training and advertising, gets additional encryption, and is deleted within 30 days of disconnecting.
The two-tier question
The launch carries caveats. Free users are served GPT-5.5 Instant while paying subscribers get GPT-5.6 Sol — and on OpenAI's own HealthBench Professional figures the gap is stark: 88.0 versus 53.2 percent on completeness, as The Decoder highlighted. OpenAI is not a HIPAA-covered entity, meaning records shared with ChatGPT lose the legal protections they carry inside hospital systems. And the timing is awkward: the rollout landed one day after a Florida man sued OpenAI alleging ChatGPT discouraged him from seeking treatment before a near-fatal pulmonary embolism. OpenAI's fine print still says the service is not intended for diagnosis or treatment.
Why it matters: this is the largest consumer AI product formally becoming a health platform, at population scale, in a regulatory vacuum — no federal framework governs health data handed to chatbots. If ChatGPT becomes the de facto front door to medical questions for hundreds of millions of Americans, the quality gap between its free and paid tiers stops being a pricing detail and becomes a public-health variable.